gainzlabuk.com
No products in the cart.
Return To Shopgainzlabuk.com
No products in the cart.
Return To ShopStrattera 25 Eli Lilly is a pharmaceutical product primarily utilized in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Unlike traditional stimulants used for this condition, Strattera contains the active ingredient atomoxetine, which is classified as a selective norepinephrine reuptake inhibitor (NRI). This medication is designed to improve focus, attention, and impulse control. Strattera plays a crucial role in the management of ADHD in both children and adults, providing a non-stimulant alternative that can be vital for patients who are sensitive to stimulant medications.
The mechanism of action of Strattera involves the inhibition of the reuptake of norepinephrine in the synaptic cleft of neurons. By increasing norepinephrine availability, Strattera enhances neurotransmission, leading to improved attention and reduced hyperactivity. In terms of metabolism, the drug is primarily metabolized in the liver by the cytochrome P450 enzyme system, particularly CYP2D6. This metabolic pathway can be influenced by various factors such as genetic polymorphisms, which can affect the drug’s efficacy.
Athletes may find that Strattera aids in improving cognitive performance during training sessions and competitions. Enhanced focus may contribute to better technique execution, strategic decision-making, and overall athletic performance, which are crucial for both competitive and recreational sports.
The benefits of Strattera extend beyond treating ADHD; it may also play a role in fitness and recovery. Athletes have reported improvements in concentration during high-pressure scenarios, which is essential for maintaining optimal performance. Additionally, Strattera helps manage anxiety symptoms, potentially reducing performance anxiety before events.
Moreover, effective focus and reduced impulsivity can lead to better training efficiency. Athletes may commit to their workout regimens more rigorously and follow nutrition plans with greater adherence, thereby optimizing recovery and performance. The medication can facilitate a calmer mindset and reduce the impact of intrusive thoughts that may hinder training.
Strattera 25 Eli Lilly is typically prescribed at an initial dose of 0.5 mg/kg for children and 40 mg for adults, which can be adjusted based on individual response. For athletes, it is crucial to follow a systematic approach based on experience and tolerance.
Beginner athletes may start with a lower dosage (e.g., 25 mg) to assess their body’s response. Once established, they can gradually increase the dosage, with a usual maintenance dose ranging from 40 to 80 mg daily. Advanced athletes may initiate at a higher baseline depending on body weight and previous experience with stimulants or norepinephrine reuptake inhibitors, generally maintaining a daily dose between 80 and 100 mg.
Consultation with healthcare professionals is essential to tailor the regimen based on personal health profiles and to monitor progress effectively.
While Strattera is generally well-tolerated, it is critical to be aware of possible side effects. Common side effects include fatigue, decreased appetite, nausea, and dry mouth. Some users may experience increased heart rate or fluctuations in blood pressure, therefore regular monitoring is essential. More serious but rare side effects include liver damage and cardiovascular events. Understanding these risks emphasizes the importance of proper use and adherence to prescribed dosages.
Failure to follow a healthcare provider’s recommendations may increase the likelihood of adverse effects, as well as potentially diminish the effectiveness of the treatment. Individuals must report any concerning symptoms for appropriate intervention.
Patients using Strattera should engage in regular follow-up appointments with healthcare providers to monitor therapeutic efficacy and side effects. Key variables to track include:
Keeping a log of daily activities and reactions can assist both the patient and healthcare provider in making informed adjustments to dosage and treatment plans.
Strattera 25 Eli Lilly can be purchased from various licensed pharmacies across the United Kingdom. However, obtaining it from an established online store can offer several advantages. Our online platform guarantees the authenticity of medications, ensuring that only certified products are available.
Reasons to choose our online store include:
By sourcing Strattera 25 Eli Lilly through our service, customers can be assured of high-quality products backed by reliable customer support, making it a prudent choice for your health and wellness needs.
| Active substance | Atomoxetine |
|---|---|
| Water Retention | None |
| Hepatotoxicity | Rare, but potential severe liver injury |
| Lab Test | Not specifically monitored through lab tests, focus is on clinical assessment |
| Also known as | Tomoxetine |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause an increase in blood pressure and heart rate |
| Trade name | Strattera |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine |
| Formula | C17H21NO |
| Substance class | Selective norepinephrine reuptake inhibitor |
| Main action | Increases norepinephrine and dopamine levels in the prefrontal cortex |
| Half-life | Approximately 5 hours |
| Dosage (medical) | Typically starts at 40 mg per day for adults, adjusted as needed |
| Dosage (sports) | Not applicable as it is not used for enhancing athletic performance |
| Effects | Improves attention, reduces impulsivity and hyperactivity in ADHD |
| Side effects | Dry mouth, insomnia, decreased appetite, increased blood pressure and heart rate |
| Use in sports | None, as it is not anabolic or performance-enhancing |
| Manufacturer | Lilly |
€531.00
€57.00
Reviews
There are no reviews yet.